Jessica Tassan
Stock Analyst at Piper Sandler
(1.08)
# 3,036
Out of 4,667 analysts
60
Total ratings
30%
Success rate
-12.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Reiterates: Overweight | $392 → $394 | $323.39 | +21.83% | 2 | Nov 5, 2024 | |
| HUM Humana | Downgrades: Neutral | $392 → $274 | $293.97 | -6.79% | 2 | Oct 3, 2024 | |
| OSCR Oscar Health | Reiterates: Overweight | $28 | $17.00 | +64.71% | 4 | Sep 10, 2024 | |
| HCAT Health Catalyst | Maintains: Overweight | $14 → $11 | $7.36 | +49.46% | 9 | Aug 26, 2024 | |
| MPLN MultiPlan | Reiterates: Neutral | $80 → $40 | $6.45 | +520.16% | 2 | Aug 7, 2024 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $8 → $10 | $11.95 | -16.32% | 4 | Aug 6, 2024 | |
| TDOC Teladoc Health | Maintains: Overweight | $25 → $10 | $9.00 | +11.11% | 4 | Aug 6, 2024 | |
| PINC Premier | Maintains: Neutral | $24 → $22 | $22.23 | -1.03% | 4 | May 8, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $566 → $571 | $600.50 | -4.91% | 4 | Apr 17, 2024 | |
| CVS CVS Health | Maintains: Overweight | $93 → $94 | $56.83 | +65.41% | 3 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $15 | $3.56 | +321.35% | 4 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $23 | $49.90 | -53.91% | 3 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $60 | $0.74 | +8,008.11% | 3 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $40 | $18.52 | +115.98% | 4 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $41.82 | +67.38% | 4 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $100 → $70 | $7.84 | +792.86% | 2 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $33 | $11.31 | +191.78% | 2 | Nov 4, 2022 |
The Cigna Group
Nov 5, 2024
Reiterates: Overweight
Price Target: $392 → $394
Current: $323.39
Upside: +21.83%
Humana
Oct 3, 2024
Downgrades: Neutral
Price Target: $392 → $274
Current: $293.97
Upside: -6.79%
Oscar Health
Sep 10, 2024
Reiterates: Overweight
Price Target: $28
Current: $17.00
Upside: +64.71%
Health Catalyst
Aug 26, 2024
Maintains: Overweight
Price Target: $14 → $11
Current: $7.36
Upside: +49.46%
MultiPlan
Aug 7, 2024
Reiterates: Neutral
Price Target: $80 → $40
Current: $6.45
Upside: +520.16%
Alignment Healthcare
Aug 6, 2024
Reiterates: Overweight
Price Target: $8 → $10
Current: $11.95
Upside: -16.32%
Teladoc Health
Aug 6, 2024
Maintains: Overweight
Price Target: $25 → $10
Current: $9.00
Upside: +11.11%
Premier
May 8, 2024
Maintains: Neutral
Price Target: $24 → $22
Current: $22.23
Upside: -1.03%
UnitedHealth Group
Apr 17, 2024
Maintains: Overweight
Price Target: $566 → $571
Current: $600.50
Upside: -4.91%
CVS Health
Mar 15, 2024
Maintains: Overweight
Price Target: $93 → $94
Current: $56.83
Upside: +65.41%
Jan 9, 2024
Maintains: Overweight
Price Target: $12 → $15
Current: $3.56
Upside: +321.35%
Nov 10, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $49.90
Upside: -53.91%
Nov 10, 2023
Downgrades: Neutral
Price Target: $60
Current: $0.74
Upside: +8,008.11%
Sep 12, 2023
Maintains: Overweight
Price Target: $43 → $40
Current: $18.52
Upside: +115.98%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $41.82
Upside: +67.38%
Feb 27, 2023
Downgrades: Neutral
Price Target: $100 → $70
Current: $7.84
Upside: +792.86%
Nov 4, 2022
Maintains: Overweight
Price Target: $40 → $33
Current: $11.31
Upside: +191.78%